Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (721-730 of 1,248) with videos related to

Pageof 125
Sort By:
Clinical Pharmacology and Therapeutics|February 1, 1984
Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepamD R Abernethy, D J Greenblatt, F N Eshelman, et al.
Arzneimittel-Forschung|January 1, 1980
Differential effects of benzodiazepine disposition by disulfiram and ethanolE M Sellers, H G Giles, D J Greenblatt, et al.
Journal of Clinical Pharmacology|April 1, 1984
Interaction of cimetidine with oxazepam, lorazepam, and flurazepamD J Greenblatt, D R Abernethy, H H Koepke, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Steady-state plasma desmethyldiazepam during long-term clorazepate use: effects of antacidsR I Shader, D A Ciraulo, D J Greenblatt, et al.
Journal of Clinical Pharmacology|September 1, 1986
Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administrationG T Blyden, D J Greenblatt, J M Scavone, et al.
Pharmacology|January 1, 1988
Antipyrine absorption and disposition in the elderlyD J Greenblatt, M K Divoll, J S Harmatz, et al.
Psychopharmacology Bulletin|January 1, 1989
Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatmentN Pomara, D Deptula, M Medel, et al.
JAMA|September 23, 1974
Equivalent bioavailability from digoxin elixir and rapid-dissolution tabletsD J Greenblatt, D W Duhme, J Koch-Weser, et al.
Connecticut Medicine|May 1, 1974
Bioavailability of digoxin: what the clinician needs to knowD J Greenblatt, D W Duhme, J Koch-Weser, et al.
Journal of Clinical and Translational Science|October 13, 2023
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populationsHarry P Selker, Dorothy Dulko, David J Greenblatt, et al.
Pageof 125

Showing results (721-730 of 1,248) with videos related to

Sort By:
Pageof 125
Clinical Pharmacology and Therapeutics|February 1, 1984
Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepamD R Abernethy, D J Greenblatt, F N Eshelman, et al.
Arzneimittel-Forschung|January 1, 1980
Differential effects of benzodiazepine disposition by disulfiram and ethanolE M Sellers, H G Giles, D J Greenblatt, et al.
Journal of Clinical Pharmacology|April 1, 1984
Interaction of cimetidine with oxazepam, lorazepam, and flurazepamD J Greenblatt, D R Abernethy, H H Koepke, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Steady-state plasma desmethyldiazepam during long-term clorazepate use: effects of antacidsR I Shader, D A Ciraulo, D J Greenblatt, et al.
Journal of Clinical Pharmacology|September 1, 1986
Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administrationG T Blyden, D J Greenblatt, J M Scavone, et al.
Pharmacology|January 1, 1988
Antipyrine absorption and disposition in the elderlyD J Greenblatt, M K Divoll, J S Harmatz, et al.
Psychopharmacology Bulletin|January 1, 1989
Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatmentN Pomara, D Deptula, M Medel, et al.
JAMA|September 23, 1974
Equivalent bioavailability from digoxin elixir and rapid-dissolution tabletsD J Greenblatt, D W Duhme, J Koch-Weser, et al.
Connecticut Medicine|May 1, 1974
Bioavailability of digoxin: what the clinician needs to knowD J Greenblatt, D W Duhme, J Koch-Weser, et al.
Journal of Clinical and Translational Science|October 13, 2023
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populationsHarry P Selker, Dorothy Dulko, David J Greenblatt, et al.
Pageof 125